OTHER NEWS - Oct. 16, 1996
Times Staff and Wire Reports
Sandoz to Buy Azupharma: The Swiss drug maker said it agreed to buy Germany’s third-largest generic drug company for $416 million from drug wholesaler Gehe of Germany. The acquisition will help boost Sandoz’s generic drug business--the stated aim of the man who will head Novartis Inc., the Swiss pharmaceutical company to be formed from the merger of Sandoz and Ciba-Geigy. Germany is the second-largest generics market in the world.
